Johnson & Johnson (JNJ) reported adjusted earnings of $1.86 per share on $22.475 billion in sales for its fourth quarter. In response, JNJ stock rose early Tuesday, signaling a fresh high.
On average, analysts polled by FactSet expected Johnson & Johnson to earn $1.82 per share on $21.66 billion in sales.
In the year-earlier period, Johnson & Johnson earnings were $1.88 per share and the company reported $20.75 billion in sales.
For full-year 2021, J&J guided to EPS of $9.40-$9.60 on revenue of $90.5 billion to $91.7 billion. Analysts called for J&J earnings of $8.96 per share and $88.6 billion in sales.
In premarket trading on the stock market today, JNJ stock rose about 2% to 169. Shares of JNJ stock broke out of a flat base and a buy point at 155.57 in December, according to MarketSmith.com. Shares are now trading at a record high.
More to follow.
Follow Allison Gatlin on Twitter at @IBD_AGatlin.
YOU MAY ALSO LIKE:
Merck Scraps Development Of ‘Inferior’ Covid Vaccines; Shares Dip
Covid Vaccines: Here’s What J&J Has To Do To Undercut Pfizer, Moderna
IBD Stock Of The Day: See How To Find, Track And Buy The Best Stocks
Find The Best Long-Term Investments With IBD Long-Term Leaders
Want To Get Quick Profits And Avoid Big Losses? Try SwingTrader